Havent been updated with the melanoma trial with keytruda/ MSD but the following
Phase I/II clinical trial (QBC46-H03) evaluating the optimal dose of our lead oncology molecule tigilanol tiglate in patients with head and neck squamous cell carcinoma (HNSCC)
cheers
- Forums
- ASX - By Stock
- Qbiotics
Havent been updated with the melanoma trial with keytruda/ MSD...
-
- There are more pages in this discussion • 471 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)